Biomarkers

• Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus.
  (Harrington J, et al. J Pediatr. 2009 Oct 22. [Epub ahead of print])
  View Abstract
• Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.
  (Matsuo M, et al. Clin Chem. 2009 Oct;55(10):1801-8. Epub 2009 Aug 6.)
  View Abstract
• Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation.
  (Parra S, et al. HIV Med. 2009 Oct 21. [Epub ahead of print])
  View Abstract
• Visfatin (Nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes.
  (Kadoglou NP, et al. Exp Clin Endocrinol Diabetes. 2009 Oct 15. [Epub ahead of print])
  View Abstract
• Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.
  (Szklo M, et al. J Cardiovasc Med (Hagerstown). 2009 Oct;10(10):747-51.)
  View Abstract
• Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis.
  (Buhlin K, et al. Atherosclerosis. 2009 Oct;206(2):518-22. Epub 2009 Apr 5.)
  View Abstract
• Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts.
  (Rizvi AA. Am J Med Sci. 2009 Oct;338(4):310-8. Review.)
  View Abstract
• Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
  (Sabio JM, et al. J Rheumatol. 2009 Oct;36(10):2204-11. Epub 2009 Sep 1.)
  View Abstract

• Performance characteristics of the new definition of diabetes: The Insulin Resistance Atherosclerosis Study (IRAS).
  (Lorenzo C, et al. Diabetes Care. 2009 Oct 30. [Epub ahead of print])
  View Abstract
• Early-stage atherosclerosis in newly diagnosed, untreated type 2 diabetes mellitus and impaired glucose tolerance.
  (Gong W, et al. Diabetes Metab. 2009 Oct 29. [Epub ahead of print])
  View Abstract
• Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study.
  (Kucharska-Newton AM, et al. Acta Diabetol. 2009 Oct 24. [Epub ahead of print])
  View Abstract
• Neighborhood resources for physical activity and healthy foods and incidence of type 2 diabetes mellitus: the Multi-Ethnic study of Atherosclerosis.
  (Auchincloss AH, et al. Arch Intern Med. 2009 Oct 12;169(18):1698-704.)
  View Abstract
• Insulin Resistance, {beta}-Cell Dysfunction, and Conversion to Type 2 Diabetes in a Multiethnic Population: The Insulin Resistance Atherosclerosis Study (IRAS).
  (Lorenzo C, et al. Diabetes Care. 2009 Oct 6. [Epub ahead of print])
  View Abstract
• High fat stores in ectopic compartments in men with newly diagnosed type 2 diabetes: an anthropometric determinant of carotid atherosclerosis and insulin resistance.
  (Kim SK, et al. Int J Obes (Lond). 2009 Oct 6. [Epub ahead of print])
  View Abstract
• Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study.
  (Hanley AJ, et al. Diabetologia. 2009 Oct;52(10):2079-86. Epub 2009 Jul 31.)
  View Abstract
• Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study.
  (Stamatelopoulos KS, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1702-8. Epub 2009 Jul 16.)
  View Abstract

Diet, Nutrition, and Metabolism

• Effects of isoflavone-supplemented soy yogurt on lipid parameters and atherosclerosis development in hypercholesterolemic rabbits: a randomized double-blind study.
  (Cavallini DC, et al. Lipids Health Dis. 2009 Oct 8;8:40.)
  View Abstract
• Associations between dietary macronutrient intake and plasma lipids demonstrate criterion performance of the Multi-Ethnic Study of Atherosclerosis (MESA) food-frequency questionnaire.
  (Nettleton JA, et al. Br J Nutr. 2009 Oct;102(8):1220-7. Epub 2009 May 19.)
  View Abstract
• The influence of raw and processed garlic and onions on plasma classical and non-classical atherosclerosis indices: investigations in vitro and in vivo.
  (Gorinstein S, et al. Phytother Res. 2009 Oct 13. [Epub ahead of print])
  View Abstract

Drug Therapy

• Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic.
  (Suckling KE. Expert Opin Investig Drugs. 2009 Oct;18(10):1425-30.)
  View Abstract
• Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis?
  (Jagielska J, et al. Atherosclerosis. 2009 Oct;206(2):390-6. Epub 2009 Mar 25.)
  View Abstract
• Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease.
  (Riley RF, et al. IDrugs. 2009 Oct;12(10):648-55.)
  View Abstract
• Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients.
  (Han SJ, et al. Nephrol Dial Transplant. 2009 Oct 28. [Epub ahead of print])
  View Abstract Gene-activators prevent and regress atherosclerosis and reduce mortality.
  (Luoma PV. Cardiovasc Hematol Agents Med Chem. 2009 Oct;7(4):295-304.)
  View Abstract
• Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
  (Takayama T, et al. Circ J. 2009 Nov;73(11):2110-7. Epub 2009 Oct 5.)
  View Abstract
• Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.
  (Brown JM, et al. Arterioscler Thromb Vasc Biol. 2009 Oct 15. [Epub ahead of print])
  View Abstract
• Effects of active components of Red Paeonia and Rhizoma chuanxiong on angiogenesis in atherosclerosis plaque in rabbits.
  (Zhang L, et al. Chin J Integr Med. 2009 Oct;15(5):359-64. Epub 2009 Oct 3.)
  View Abstract
• The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.
  (Watson AM, et al. Diabetologia. 2009 Oct 28. [Epub ahead of print])
  View Abstract
• Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.
  (Kaur-Knudsen D, et al. Pharmacogenomics J. 2009 Oct;9(5):327-32. Epub 2009 Aug 4.)
  View Abstract

Epidemiology

• The Family Atherosclerosis Monitoring In earLY life (FAMILY) study: rationale, design, and baseline data of a study examining the early determinants of atherosclerosis.
  (Morrison KM, et al. Am Heart J. 2009 Oct;158(4):533-9. Epub 2009 Aug 28.)
  View Abstract
• Classification and atherosclerosis distribution in patients with left main coronary disease.
  (Thompson CA, et al. J Interv Cardiol. 2009 Oct;22(5):431-6. Epub 2009 Jul 13.)
  View Abstract
• Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus.
  (de Leeuw K, et al. Atherosclerosis. 2009 Oct;206(2):546-50. Epub 2009 Mar 25.)
  View Abstract

• Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant.
  (Sarzani R, et al. Nutr Metab Cardiovasc Dis. 2009 Oct 13. [Epub ahead of print])
  View Abstract
• Pleiotropic role of growth arrest-specific gene 6 in atherosclerosis.
  (Tjwa M, et al. Curr Opin Lipidol. 2009 Oct;20(5):386-92.)
  View Abstract
• Recipient genetic determinants of inflammatory process and nonstandard atherosclerosis risk factors affect kidney graft function early posttransplantation.
  (Krajewska M, et al. Transplant Proc. 2009 Oct;41(8):3060-2.)
  View Abstract
• Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.
  (Chen SN, et al. BMC Med Genet. 2009 Oct 30;10:111.)
  View Abstract
• Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis.
  (Muendlein A, et al. Atherosclerosis. 2009 Oct;206(2):494-9. Epub 2009 Mar 19.)
  View Abstract
• The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice.
  (Wade NS, et al. Lupus. 2009 Oct 22. [Epub ahead of print])
  View Abstract
• Increased risk for atherosclerosis of various macrophage scavenger receptor 1 alleles.
  (Durst R, et al. Genet Test Mol Biomarkers. 2009 Oct;13(5):583-7.)
  View Abstract

• An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.
  (McAteer MA, et al. Atherosclerosis. 2009 Oct 12. [Epub ahead of print])
  View Abstract
• Molecular Imaging of the Initial Inflammatory Response in Atherosclerosis. Implications for Early Detection of Disease.
  (Kaufmann BA, et al. Arterioscler Thromb Vasc Biol. 2009 Oct 15. [Epub ahead of print])
  View Abstract
• 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
  (Nahrendorf M, et al. JACC Cardiovasc Imaging. 2009 Oct;2(10):1213-22.)
  View Abstract
• Carotid magnetic resonance imaging. A window to study atherosclerosis and identify high-risk plaques.
  (Oikawa M, et al. Circ J. 2009 Oct;73(10):1765-73. Epub 2009 Sep 15.)
  View Abstract
• Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors.
  (Nahrendorf M, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1444-51. Epub 2009 Jul 16.)
  View Abstract
• The mainstream hypothesis that LDL cholesterol drives atherosclerosis may have been falsified by non-invasive imaging of coronary artery plaque burden and progression.
  (Ware WR. Med Hypotheses. 2009 Oct;73(4):596-600. Epub 2009 Jun 26.)
  View Abstract
• Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection.
  (Calza L, et al. Int J STD AIDS. 2009 Oct;20(10):683-9.)
  View Abstract
• Prevalence and distribution of sub-clinical atherosclerosis by screening vascular ultrasound in low and intermediate risk adults: the New York physicians study.
  (Postley JE, et al. J Am Soc Echocardiogr. 2009 Oct;22(10):1145-51.)
  View Abstract
• High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.
  (Skajaa T, et al. Arterioscler Thromb Vasc Biol. 2009 Oct 8. [Epub ahead of print])
  View Abstract
• Primary congenital anomalies of the coronary arteries and relation to atherosclerosis: an angiographic study in Lebanon.
  (Eid AH, et al. J Cardiothorac Surg. 2009 Oct 29;4:58.)
  View Abstract
• Assessment of subclinical coronary atherosclerosis in asymptomatic patients with type 2 diabetes mellitus with single photon emission computed tomography and coronary computed tomography angiography.
  (Choi EK, et al. Am J Cardiol. 2009 Oct 1;104(7):890-6.)
  View Abstract
• Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions.
  (Ueno K, et al. Circ J. 2009 Oct;73(10):1927-33. Epub 2009 Aug 19.)
  View Abstract

Immunology

• Atherosclerosis in survivors of Kawasaki disease.
  (Gupta-Malhotra M, et al. J Pediatr. 2009 Oct;155(4):572-7.)
  View Abstract
• Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice.
  (Feng J, et al. Cardiovasc Res. 2009 Oct 1;84(1):155-63. Epub 2009 Jun 5.)
  View Abstract
• Autoimmunity, infectious immunity, and atherosclerosis.
  (Matsuura E, et al. J Clin Immunol. 2009 Oct 1. [Epub ahead of print])
  View Abstract
• The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.
  (Engel D, et al. Semin Immunol. 2009 Oct;21(5):308-12. Epub 2009 Jul 17.)
  View Abstract
• Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice.
  (Leung VW, et al. Am J Pathol. 2009 Oct;175(4):1757-67. Epub 2009 Sep 3.)
  View Abstract

Inflammation

• Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: Long-term follow-up of the Atherosclerosis Risk in Communities (ARIC) Cohort.
  (Kucharska-Newton AM, et al. Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2182-2190. Epub 2009 Oct 1.)
  View Abstract
• Increased PAFAH and oxidized lipids are associated with inflammation and atherosclerosis in hypercholesterolemic pigs.
  (De Keyzer D, et al. Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2041-2046. Epub 2009 Oct 1.)
  View Abstract
• W Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: Pro-inflammatory effect on atherosclerosis.
  (Guo F, et al. Biochem Biophys Res Commun. 2009 Oct 21. [Epub ahead of print])
  View Abstract
• Human plasminogen kringle 1-5 reduces atherosclerosis and neointima formation in mice by suppressing the inflammatory signaling pathway.
  (Chang PC, et al. J Thromb Haemost. 2009 Oct 30. [Epub ahead of print])
  View Abstract
• Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice.
  (Zhang D, et al. Circulation. 2009 Nov 10;120(19):1893-902. Epub 2009 Oct 26.)
  View Abstract
• Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis.
  (Orr AW, et al. J Vasc Res. 2009 Oct 22;47(2):168-180. [Epub ahead of print])
  View Abstract

Innovative Techniques / Modeling

• Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis.
  (Nam D, et al. Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1535-43. Epub 2009 Aug 14.)
  View Abstract

Lifestyle

• Physical activity and physiologic cardiac remodeling in a community setting: the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Turkbey EB, et al. Heart. 2009 Oct 26. [Epub ahead of print])
  View Abstract
• Association of exercise capacity and the heart rate profile during exercise stress testing with subclinical coronary atherosclerosis: data from the Heinz Nixdorf Recall study.
  (Möhlenkamp S, et al. Clin Res Cardiol. 2009 Oct;98(10):665-76. Epub 2009 Aug 20.)
  View Abstract
• Exercise training decreases store-operated Ca2+entry associated with metabolic syndrome and coronary atherosclerosis.
  (Edwards JM, et al. Cardiovasc Res. 2009 Oct 4. [Epub ahead of print])
  View Abstract
• Smoking cessation and carotid atherosclerosis: The Guangzhou Biobank Cohort Study-CVD.
  (Jiang CQ, et al. J Epidemiol Community Health. 2009 Oct 12. [Epub ahead of print])
  View Abstract

Lipid / Lipoprotein Metabolism

• Androgen deficiency and atherosclerosis: The lipid link.
  (Traish AM, et al. Vascul Pharmacol. 2009 Nov-Dec;51(5-6):303-13. Epub 2009 Oct 6.)
  View Abstract
• Lipoprotein modification by secretory phospholipase A(2) enzymes contributes to the initiation and progression of atherosclerosis.
  (Oörni K, et al. Curr Opin Lipidol. 2009 Oct;20(5):421-7.)
  View Abstract

• Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease.
  (Sookoian S, et al. Atherosclerosis. 2009 Oct 13. [Epub ahead of print])
  View Abstract

• Life course socioeconomic conditions and metabolic syndrome in adults: The Atherosclerosis Risk in Communities (ARIC) Study.
  (Chichlowska KL, et al. Ann Epidemiol. 2009 Oct 3. [Epub ahead of print])
  View Abstract
• Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
  (Alberti KG, et al. Circulation. 2009 Oct 20;120(16):1640-5. Epub 2009 Oct 5.)
  View Abstract

• Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis.
  (Titterington JS, et al. Endocrinology. 2009 Oct 9. [Epub ahead of print])
  View Abstract
• Roles of oxidative stress and redox regulation in atherosclerosis.
  (Kondo T, et al. J Atheroscler Thromb. 2009 Oct;16(5):532-8. Epub 2009 Sep 14.)
  View Abstract

Pediatrics

• An 11-year-old boy with familial hypercholesterolemia showing multiple xanthomas and advanced atherosclerosis, who responded to lipid-lowering therapy using statin.
  (Ohshiro T, et al. J Atheroscler Thromb. 2009 Oct;16(5):698-701. Epub 2009 Aug 27.)
  View Abstract

Plaque Biology

• Toll like receptor 4 in atherosclerosis and plaque destabilization.
  (den Dekker WK, et al. Atherosclerosis. 2009 Oct 12. [Epub ahead of print])
  View Abstract

• Arterial atherosclerosis in patients with chronic kidney disease and its relationship with serum and tissue.
  (Noshad H, et al. Iran J Kidney Dis. 2009 Oct;3(4):203-9.)
  View Abstract
• Which components of malnutrition-inflammation-atherosclerosis syndrome are more common in haemodialysis patients with diabetic nephropathy?
  (Jakuszewski P, et al. Nephrology (Carlton). 2009 Oct;14(7):643-9. Epub 2009 Jul 9.)
  View Abstract

• Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
  (Nordestgaard BG, et al. Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):521-4. Epub 2009 Aug 19.)
  View Abstract

• Lesion patterns and stroke mechanisms in concurrent atherosclerosis of intracranial and extracranial vessels.
  (Man BL, et al. Stroke. 2009 Oct;40(10):3211-5. Epub 2009 Jul 30.)
  View Abstract
• Mirror pattern of cerebral artery atherosclerosis in patients with ischaemic stroke.
  (Kim YD, et al. Eur J Neurol. 2009 Oct;16(10):1159-64. Epub 2009 May 22.)
  View Abstract
• Carotid atherosclerosis and a reduced likelihood for lowered cognitive performance in a Canadian First Nations population.
  (Fergenbaum JH, et al. Neuroepidemiology. 2009 Oct 30;33(4):321-328. [Epub ahead of print])
  View Abstract
• Protective modulation of carotid atherosclerosis in hyperalphalipoproteinemic individuals.
  (Santiago FD, et al. Int J Cardiovasc Imaging. 2009 Oct 30. [Epub ahead of print])
  View Abstract
• The relationships among serum glucose, albumin concentrations and carotid atherosclerosis in men with spinal cord injury.
  (Wang YH, et al. Atherosclerosis. 2009 Oct;206(2):528-34. Epub 2009 Mar 14.)
  View Abstract
• Association between central systolic blood pressure, white matter lesions in cerebral MRI and carotid atherosclerosis.
  (Shrestha I, et al. Hypertens Res. 2009 Oct;32(10):869-74. Epub 2009 Jul 31.)
  View Abstract
• Hopelessness, depressive symptoms, and carotid atherosclerosis in women: the Study of Women's Health Across the Nation (SWAN) heart study.
  (Whipple MO, et al. Stroke. 2009 Oct;40(10):3166-72. Epub 2009 Aug 27.)
  View Abstract

Vascular Biology

• Heparin cofactor II as a novel vascular protective factor against atherosclerosis.
  (Aihara K, et al. J Atheroscler Thromb. 2009 Oct;16(5):523-31. Epub 2009 Sep 3.)
  View Abstract
• Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification.
  (Burton DG, et al. Exp Gerontol. 2009 Oct;44(10):659-65. Epub 2009 Jul 23.)
  View Abstract
• Macrophage cholesteryl ester mobilization and atherosclerosis.
  (Ghosh S, et al. Vascul Pharmacol. 2009 Oct 28. [Epub ahead of print])
  View Abstract
• Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis.
  (Swirski FK, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1424-32. Epub 2009 Apr 16. Review.)
  View Abstract
• Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based study.
  (Deans KA, et al. BMJ. 2009 Oct 27;339:b4170. doi: 10.1136/bmj.b4170.)
  View Abstract
• {beta}2 integrins modulate the initiation and progression of atherosclerosis in LDLR knockout mice.
  (Merched A, et al. Cardiovasc Res. 2009 Oct 20. [Epub ahead of print])
  View Abstract
• Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up MESA (Multi-Ethnic Study of Atherosclerosis).
  (Rosen BD, et al. JACC Cardiovasc Imaging. 2009 Oct;2(10):1175-83.)
  View Abstract
• Low bone mineral density is related to atherosclerosis in postmenopausal Moroccan women.
  (Hmamouchi I, et al. BMC Public Health. 2009 Oct 14;9:388.)
  View Abstract
• Chylomicronemia Elicits Atherosclerosis in Mice.
  (Weinstein MM, et al. Arterioscler Thromb Vasc Biol. 2009 Oct 8. [Epub ahead of print])
  View Abstract
• Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints.
  (Teul J, et al. J Proteome Res. 2009 Oct 9. [Epub ahead of print])
  View Abstract
• High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
  (Basta G, et al. Eur J Clin Invest. 2009 Dec;39(12):1065-72. Epub 2009 Oct 7.)
  View Abstract
• Thyroid hormone and atherosclerosis.
  (Ichiki T. Vascul Pharmacol. 2009 Oct 4. [Epub ahead of print])
  View Abstract
• The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis.
  (Sandberg WJ, et al. Thromb Haemost. 2009 Oct;102(4):704-10.)
  View Abstract
• Coronary atherosclerosis in sudden cardiac death: an autopsy study.
  (Sudha ML, et al. Indian J Pathol Microbiol. 2009 Oct-Dec;52(4):486-9.)
  View Abstract
• Association of electrocardiographic abnormalities with coronary artery calcium and carotid artery intima-media thickness in individuals without clinical coronary heart disease (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
  (Lloyd-Jones DM, et al. Am J Cardiol. 2009 Oct 15;104(8):1086-91.)
  View Abstract
• Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule.
  (Rohatgi A, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1684-90.)
  View Abstract
• Estrogen decreases atherosclerosis in part by reducing hepatic acyl-CoA:cholesterol acyltransferase 2 (ACAT2) in monkeys.
  (Kavanagh K, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1471-7.)
  View Abstract
• Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis.
  (Gautier EL, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1412-8. Review.)
  View Abstract
• A role of matrix metalloproteinase-8 in atherosclerosis.
  (Laxton RC, et al. Circ Res. 2009 Oct 23;105(9):921-9. Epub 2009 Sep 10.)
  View Abstract
• Correlation between the levels of circulating adhesion molecules and atherosclerosis in type-2 diabetic normotensive patients: Circulating adhesion molecules and atherosclerosis.
  (Rubio-Guerra AF, et al. Cell Adh Migr. 2009 Oct 7;3(4). [Epub ahead of print])
  View Abstract
• Macrophage diversity and polarization in atherosclerosis: a question of balance.
  (Mantovani A, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1419-23. Epub 2009 Aug 20. Review.)
  View Abstract
• Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
  (van Es T, et al. Biochem Biophys Res Commun. 2009 Oct 16;388(2):261-5. Epub 2009 Aug 4.)
  View Abstract
• The role of hypoxia in atherosclerosis.
  (Hultén LM, et al. Curr Opin Lipidol. 2009 Oct;20(5):409-14.)
  View Abstract
• Ischemia modified albumin, high-sensitivity c-reactive protein and natriuretic peptide in patients with coronary atherosclerosis.
  (Kazanis K, et al. Clin Chim Acta. 2009 Oct;408(1-2):65-9. Epub 2009 Jul 19.)
  View Abstract
• Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E.
  (Merino VF, et al. J Mol Med. 2009 Oct;87(10):953-63. Epub 2009 Jul 18.)
  View Abstract
• Current status of rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasm.
  (Dong M, et al. Cardiovasc Hematol Agents Med Chem. 2009 Oct;7(4):322-30.)
  View Abstract
• Relationship between circulating FGF23 and total body atherosclerosis in the community.
  (Mirza MA, et al. Nephrol Dial Transplant. 2009 Oct;24(10):3125-31. Epub 2009 May 9.)
  View Abstract
• Lipoprotein-associated phospholipase A(2) and atherosclerosis.
  (Wilensky RL, et al. Curr Opin Lipidol. 2009 Oct;20(5):415-20.)
  View Abstract
• Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice.
  (Jun J, et al. Atherosclerosis. 2009 Oct 17. [Epub ahead of print])
  View Abstract
• Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis.
  (Pham Y, et al. Diabetologia. 2009 Oct 22. [Epub ahead of print])
  View Abstract
• Liver X receptors as potential therapeutic targets in atherosclerosis.
  (Zhu Y, et al. Clin Invest Med. 2009 Oct 1;32(5):E383-94.)
  View Abstract

Vascular Calcification

• Relationship of carotid distensibility and thoracic aorta calcification: Multi-Ethnic Study of Atherosclerosis.
  (Blaha MJ, et al. Hypertension. 2009 Dec;54(6):1408-1415. Epub 2009 Oct 5.)
  View Abstract
• Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Budoff MJ, et al. Am Heart J. 2009 Oct;158(4):554-61.)
  View Abstract

The following articles were recommended by Eder Quintão, MD

• The molecular mechanisms of HDL and associated vesicular trafficking mechanisms to mediate cellular lipid homeostasis.
  (Schmitz G, et al. Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1718-22.)
  View Abstract
• Moderately decreased cholesterol absorption rates are associated with a large atheroprotective effect.
  (Greenberg ME, et al. Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1745-50. Epub 2009 Aug 6.)
  View Abstract
• Familial Combined Hyperlipidemia Is Associated With Alterations in the Cholesterol Synthesis Pathway.
  (van Himbergen TM, et al. Arterioscler Thromb Vasc Biol. 2009 Oct 15. [Epub ahead of print])
  View Abstract
• Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor.
  (Masson D, et al. Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2054-60. Epub 2009 Oct 8.)
  View Abstract
• Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice.
  (Kennedy DJ, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1481-7. Epub 2009 Jul 16.)
  View Abstract
• Fish oil promotes macrophage reverse cholesterol transport in mice.
  (Nishimoto T, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1502-8. Epub 2009 Jul 2.)
  View Abstract
• Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses.
  (Yvan-Charvet L, et al. Arterioscler Thromb Vasc Biol. 2009 Oct 1. [Epub ahead of print])
  View Abstract
• PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia.
  (Cariou B, et al. Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2191-7. Epub 2009 Sep 17.)
  View Abstract
• Statins for the prevention and treatment of infections: a systematic review and meta-analysis.
  (Tleyjeh IM, et al. Arch Intern Med. 2009 Oct 12;169(18):1658-67. Review.)
  View Abstract
• Cholesterol homeostasis in ABCA1/LCAT double-deficient mouse.
  (Hossain MA, et al. Biochim Biophys Acta. 2009 Dec;1791(12):1197-205. Epub 2009 Sep 1.)
  View Abstract
• Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route.
  (Poirier S, et al. J Biol Chem. 2009 Oct 16;284(42):28856-64. Epub 2009 Jul 27.)
  View Abstract
• Bile acids: Role of peroxisomes.
  (Ferdinandusse S, et al. J Lipid Res. 2009 Apr 8. [Epub ahead of print])
  View Abstract
• Mechanism of inhibition defines CETP activity: A mathematical model for CETP in vitro.
  (Potter LK, et al. J Lipid Res. 2009 Mar 11. [Epub ahead of print])
  View Abstract
• Influence of class B scavenger receptors on cholesterol flux across the brush border membrane and intestinal absorption.
  (Nguyen DV, et al. J Lipid Res. 2009 May 19. [Epub ahead of print])
  View Abstract
• LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.
  (Zelcer N, et al. Science. 2009 Jul 3;325(5936):100-4. Epub 2009 Jun 11.
  View Abstract